期刊文献+

治疗骨质疏松症药物研究进展(二) 被引量:3

暂未订购
导出
出处 《现代医药卫生》 2006年第12期1821-1822,共2页 Journal of Modern Medicine & Health
  • 相关文献

参考文献14

  • 1Albrecht WE ,Christine B ,Christoph S ,et al.Prevention of postmenopausl bone loss with long-cycle hormone replacement therapy[J]. Maturitas, 2006,53(2): 191.
  • 2Helenius J, Kloosterboer. Tissue-selectivity: the mechanism of action of tibolone[J]. Maturitas ,2004,48(S1): S30.
  • 3Bernard C ,Anne BL,Patrick G. Comparative efficacy and safety study of etidronate and alendronate in postmenopausal osteoporosis.Effect of adding hormone replacement therapy[J]. Joint Bone Spine,2001,68:410.
  • 4Ferenc S, Dalma H, Peter LL. High serum osteoprotegerin and low RANKL in primary biliary cirrhosis[J]. Journal of Hepatology ,2003,38:395.
  • 5Lufkin EG ,Wong M, Deal C. The role of selective estrogen receptor modulators in the prevention and treTAMent of osteoporosis[J]. Rheumatic Disease Clinics of North America,2001,27(1): 163.
  • 6Licata AA,Ciaccia AV,Wong M. Raloxifene :a new choice for treating and preventing osteoporosis[J]. Cleveland Clinic Journal of Medicine,2000,64(4) : 273.
  • 7Marie LG,Scheele WH ,Jasque RS. Bone mineral density changes during an 18 month observational period following discontinuation of recombinant human parathyroid hormone(1-34) treTAMent of postmenopausal women receiving hormone replacement therapy[J]. Arthritis & Rheum,2001,44(S) :S257.
  • 8Kulkarni PM, Gaich GA, Seheele WH. Lumbar spine bone mineral density response rotes in a study of recombinant human parathyroid hormone(1-34) compared to alendronate sodium in postmenopausal women with osteoporosis[J] .Arthritis & Rheum, 2001 ,44(S):S379.
  • 9Orwoll E,Scheele WH, Paul S. Brief therapy with recombinant human parathyroid hormone(1-34) increase lumbar spine bone mineral density in men with idiopathic or hypogonadal osteoporosis[J].Journal of Bone Mineral Research,2001,16(S1):S221.
  • 10Lindsay R,Scheele WH ,Clancy AD. Incident vertebral fractures during an 18 month observation period following discontinuation of LY333334[recombinant human parathyroid hormone(1-34) , rhFFH(1-34)] use in postmenopausal women with osteoporosis[J].Journal of Bone Mineral Research,2001,16(S1):S163.

共引文献21

同被引文献19

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部